Ars Pharms Operation Company Profile
What is the competitive landscape for ARS PHARMS OPERATION
ARS PHARMS OPERATION has one approved drug.
There are eight US patents protecting ARS PHARMS OPERATION drugs.
Summary for Ars Pharms Operation
| US Patents: | 8 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Ars Pharms Operation
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ars Pharms Operation | NEFFY | epinephrine | SPRAY;NASAL | 214697-001 | Aug 9, 2024 | RX | Yes | Yes | 11,717,571 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ars Pharms Operation | NEFFY | epinephrine | SPRAY;NASAL | 214697-001 | Aug 9, 2024 | RX | Yes | Yes | 11,191,838 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Ars Pharms Operation | NEFFY | epinephrine | SPRAY;NASAL | 214697-001 | Aug 9, 2024 | RX | Yes | Yes | 11,744,895 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ars Pharms Operation | NEFFY | epinephrine | SPRAY;NASAL | 214697-001 | Aug 9, 2024 | RX | Yes | Yes | 11,918,655 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Ars Pharms Operation | NEFFY | epinephrine | SPRAY;NASAL | 214697-002 | Mar 5, 2025 | RX | Yes | Yes | 11,918,655 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ars Pharms Operation | NEFFY | epinephrine | SPRAY;NASAL | 214697-001 | Aug 9, 2024 | RX | Yes | Yes | 10,682,414 | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Ars Pharms Operation Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Poland | 3678649 | ⤷ Start Trial |
| Ukraine | 130423 | ⤷ Start Trial |
| Montenegro | 04499 | ⤷ Start Trial |
| European Patent Office | 2629786 | ⤷ Start Trial |
| South Korea | 20220035512 | ⤷ Start Trial |
| Croatia | P20221525 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Ars Pharms Operation Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 3678649 | 301317 | Netherlands | ⤷ Start Trial | PRODUCT NAME: COMBINATIE VAN EPINEFRINE OF EEN ZOUT DAARVAN, EN DODECYLMALTOSIDE; REGISTRATION NO/DATE: EU1/24/1846 20240823 |
| 3678649 | C20250011 | Finland | ⤷ Start Trial | |
| 3678649 | PA2025507 | Lithuania | ⤷ Start Trial | PRODUCT NAME: VISU FORMU EPINEFRINO IR DODECILMALTOZIDO DERINYS SAUGOMASPAGRINDINIO PATENTO; REGISTRATION NO/DATE: EU/1/24/1846 20240822 |
| 3678649 | 2025C/508 | Belgium | ⤷ Start Trial | PRODUCT NAME: COMBINATIE VAN EPINEPHRINE EN DODECYLMALTOSIDE, IN ALLE VORMEN BESCHERMD DOOR HET BASISOCTROOI; AUTHORISATION NUMBER AND DATE: EU/1/24/1846 20240823 |
| 3678649 | CA 2025 00007 | Denmark | ⤷ Start Trial | PRODUCT NAME: KOMBINATION AF EPINEPHRIN ELLER ET SALT DERAF, OG DODECYLMATOSID; REG. NO/DATE: EU/1/24/1846 20240823 |
| 3678649 | LUC00378 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: COMBINAISON D'EPINEPHRINE ET DE DODECYLMALTOSIDE, SOUS TOUTES SES FORMES PROTEGEES PAR LE BREVET DE BASE; AUTHORISATION NUMBER AND DATE: EU/1/24/1846 20250211 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
